Step 2 — Surveying the peaks
Identifying targetable driver alterations
In partnership with academic and clinical collaborators and diagnostic leaders, Elevation Oncology actively evaluates emerging genomic research for true oncogenic driver alterations with a druggable pathway.
Oncogenic Fusion and Driver Mutation Collaboration
We are excited to announce a joint collaboration with Caris Life Sciences to accelerate the identification of targetable driver alterations, and develop potential therapies that could make them actionable.Learn more